Mark Sculpher

University of York

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Annick Borquez

University of California, San Diego

UNITED STATES

View details

Paul Revill

Professor

University of York

UNITED KINGDOM

View details

Paul Kaye

Professor of Immunology

University of York

UNITED KINGDOM

View details

Bethan Sarah Woods

University of York

UNITED KINGDOM

View details

Abigail Colson

University Of Strathclyde

UNITED KINGDOM

View details

Noemi Kreif

UNITED KINGDOM

View details

Andrew Metry

University of Sheffield

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mark Sculpher

Research Interests

Explore related searches

Contact this professor

Articles (14)

Correction: A Framework for Using Cost‑effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and Evidence

Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision Making

A Framework for Using Cost-effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and Evidence

Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates

Using Economic Evaluation to Inform Responses to the Opioid Epidemic in the United States: Challenges and Suggestions for Future Research

Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response: A Review of UK Studies

Developing the EQ-5D-5L Value Set for Uganda Using the 'Lite' Protocol.

Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?

Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems.

Program Evaluation of Population- and System-Level Policies: Evidence for Decision Making.

Methodological issues in economic evaluations of emergency transport systems in low-income and middle-income countries.

Authors' Response to: "Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al." by Sampson, Firth, and Towse.

Ideas About Resourcing Health Care in the United States: Can Economic Evaluation Achieve Meaningful Use?

From impact evaluation to decision-analysis: assessing the extent and quality of evidence on ‘value for money’ in health impact evaluations in low- and middle-income countries

Collaborators (7)

Annick Borquez

Paul Revill

Paul Kaye

Bethan Sarah Woods

Abigail Colson

Noemi Kreif

Andrew Metry

Make your next move.